Birija Sankar Patro

13PUBLICATIONS
31CO-AUTHORS
Molecular targetsComposite and hybrid materialsTe wairua auaha o te Māori (Māori innovation)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jul 07, 2026
Targeting lysosomes with a novel chloroquine derivative induces irreversible lysosomal damage and disrupts autophagosome and lysosome assembly in cancer.

|May 13, 2026
A CHK1-mediated phosphorylation switch suppresses human Topoisomerase 1-associated genomic instability.

|Jun 17, 2025
Correction: Targeting autophagy reverses de novo resistance in homologous recombination repair proficient breast cancers to PARP inhibition.

Ganesh Pai Bellare, Bhaskar Saha, Birija Sankar Patro

|Jun 10, 2025
Robust Hydrogen-Bonded Organic Framework for pH-Responsive Drug Delivery.

Sucheta Chatterjee, Mrityunjay Tyagi, Ayan Ghosh

|Jun 09, 2025
Synthesis, Structure-Activity Relationship, and Biological Evaluation of a Novel Malabaricone Derivative: A Potent Anticancer Agent and Radiosensitizer That Targets Autophagy Flux.

Kshama Kundu, Mrityunjay Tyagi, Sudip Gorai

|Mar 16, 2025
Targeting Replication Fork Processing Synergizes with PARP Inhibition to Potentiate Lethality in Homologous Recombination Proficient Ovarian Cancers.

Ganesh Pai Bellare, Kshama Kundu, Papiya Dey

Pageof 3

Frequent Collaborators

4 joint publications

Ganesh Pai Bellare

3 joint publications

Nitish Chauhan

2 joint publications

Dibakar Goswami

2 joint publications

Soumyaditya Mula